BSE - Free Realtime Quote INR

Morepen Laboratories Limited (MOREPENLAB.BO)

Compare
79.39 +1.49 (+1.91%)
As of 10:44 AM GMT+5:30. Market Open.
Loading Chart for MOREPENLAB.BO
DELL
  • Previous Close 77.90
  • Open 78.01
  • Bid 79.37 x --
  • Ask 79.47 x --
  • Day's Range 77.90 - 79.70
  • 52 Week Range 38.56 - 100.80
  • Volume 424,203
  • Avg. Volume 1,162,448
  • Market Cap (intraday) 43.502B
  • Beta (5Y Monthly) 1.49
  • PE Ratio (TTM) 31.38
  • EPS (TTM) 2.53
  • Earnings Date Jan 29, 2025 - Feb 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 18, 2002
  • 1y Target Est --

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

www.morepen.com

2,152

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MOREPENLAB.BO

View More

Performance Overview: MOREPENLAB.BO

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MOREPENLAB.BO
63.59%
S&P BSE SENSEX
10.26%

1-Year Return

MOREPENLAB.BO
71.03%
S&P BSE SENSEX
20.36%

3-Year Return

MOREPENLAB.BO
57.05%
S&P BSE SENSEX
39.47%

5-Year Return

MOREPENLAB.BO
396.19%
S&P BSE SENSEX
93.65%

Compare To: MOREPENLAB.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MOREPENLAB.BO

View More

Valuation Measures

Annual
As of 11/28/2024
  • Market Cap

    42.69B

  • Enterprise Value

    40.98B

  • Trailing P/E

    30.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.31

  • Price/Book (mrq)

    3.84

  • Enterprise Value/Revenue

    2.34

  • Enterprise Value/EBITDA

    19.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.40%

  • Return on Assets (ttm)

    8.31%

  • Return on Equity (ttm)

    13.88%

  • Revenue (ttm)

    17.75B

  • Net Income Avi to Common (ttm)

    1.31B

  • Diluted EPS (ttm)

    2.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.86B

  • Total Debt/Equity (mrq)

    3.02%

  • Levered Free Cash Flow (ttm)

    -669.34M

Research Analysis: MOREPENLAB.BO

View More

Company Insights: MOREPENLAB.BO

Research Reports: MOREPENLAB.BO

View More

People Also Watch